TABLE 1.
Factor | No. of Patients (%) or Median (IQR) |
---|---|
initial CSF shunt placement | |
age | |
≤30 days | 233 (34.5) |
1–6 mos | 200 (29.6) |
6–48 mos | 152 (22.5) |
≥48 mos | 90 (13.3) |
sex | |
male | 362 (53.6) |
female | 313 (46.4) |
race/ethnicity* | |
non-Latino black | 160 (25.0) |
Latino | 78 (12.2) |
Asian | 15 (2.3) |
other | 65 (10.2) |
non-Latino white | 321 (50.2) |
payer | |
public | 349 (51.7) |
private | 188 (27.9) |
other | 138 (20.4) |
indication for CSF shunt placement | |
IVH | 77 (11.4) |
myelomeningocele | 72 (10.7) |
CNS tumor | 60 (8.9) |
trauma | 10 (1.5) |
meningitis | 18 (2.7) |
comorbidities† | |
none | 459 (68.0) |
1 | 176 (26.1) |
≥2 | 40 (5.9) |
distal shunt location | |
VP | 661 (97.9) |
other | 14 (2.1) |
initial CSF shunt infection | |
age | |
≤30 days | 23 (3.4) |
1–6 mos | 240 (35.6) |
6–48 mos | 281 (41.6) |
≥48 mos | 131 (19.4) |
interval CSF shunt revisions | 1 (1, 2) |
interval time from initial shunt placement (days) | 72 (27–340) |
interval time from last op (days) | 34 (17–97) |
hospital vol‡ | |
1–20 | 35 (5.2) |
21–40 | 186 (27.6) |
41–60 | 330 (50.1) |
≥61 | 116 (17.2) |
surgeon vol‡ | |
≤10 | 213 (31.6) |
11–20 | 265 (39.3) |
30 | 108 (16.0) |
>30 | 89 (13.2) |
op approach to initial shunt infection (483 patients) § | |
shunt removal/new shunt placement | 286 (59.2) |
externalization | 59 (12.2) |
nonop management | 64 (13.3) |
complete shunt removal | 74 (15.3) |
duration of intravenous antibiotic use (days) | 9 (0–16) |
Race/ethnicity data were missing for 36 children.
Chronic medical condition count.
The volume represents the number of initial CSF shunt placements/year.
Those whose surgical assignments could not be determined were excluded.